2021-09-17
Small for gestational age: Adult metabolic and cardiovascular health and long-term safety of growth hormone treatment
Publication
Publication
This thesis describes the concluding research that has been conducted in a large population of (young) adults who were born small for gestational age (SGA). Around 10% of children born SGA, do not experience catch-up growth, which leads to persistent short stature until adulthood. Growth hormone treatment and postponing puberty with gonadotropin-releasing hormone agonist (GnRHa) can lead to sufficient catch-up in height, which results in an adult height within the normal range. However, long-term effects of SGA birth, growth hormone and GnRHa treatment were unknown. We describe long-term effects of SGA birth and these treatments on metabolic and cardiovascular health, body composition, bone mineral density, kidney function, cognition and psychosocial functioning.
Additional Metadata | |
---|---|
, , , , , , , , , , , , , , , , , , , | |
A.C.S. Hokken-Koelega (Anita) | |
Erasmus University Rotterdam | |
hdl.handle.net/1765/135685 | |
Organisation | Department of Pediatrics |
Goedegebuure, W.J. (2021, September 17). Small for gestational age: Adult metabolic and cardiovascular health and long-term safety of growth hormone treatment. Erasmus University Rotterdam. Retrieved from http://hdl.handle.net/1765/135685
|
Additional Files | |
---|---|
stellingen-behorende-bij-het-proefschrift.pdf , 141kb | |
cover-image-goedegebuure.PNG Cover Image , 94kb |